D-0498-2025 Class II Ongoing

Recalled by Tailstorm Health INC — Phoenix, AZ

FDA drug recall D-0498-2025 was initiated by Tailstorm Health INC on Jun 2, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process. The recall status is ongoing. Affected quantity: 29,700 vials.

Recall details

Product Type
Drugs
Report Date
Jul 9, 2025
Initiation Date
Jun 2, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
29,700 vials

Product description

LIDOcaine HCl Injection, USP, 10mg/mL, 1% (100 mg/10mL), 10 mL Sterile Single Dose Vial, Rx Only, For Infiltration & Nerve Block, Including Caudal & Epidural Use, Preservative-Free, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0000-0.

Reason for recall

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

Distribution pattern

Nationwide in the US

Code information

Lot #s: 2502004, Exp. 2/18/27; 2503003, Exp. 3/19/27

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0498-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0498-2025. Report a data issue: hello@regdatalab.com.